Sociedad Química y Minera de Chile S.A. (SQM) Analyse boursière

Présentation de l'entreprise

Sociedad Química y Minera de Chile S.A. operates as a leading global manufacturer specializing in the production and sale of specialty plant nutrients, iodine, and its derivatives to markets worldwide. Within the broader Basic Materials sector, the firm functions specifically within the Specialty Chemicals industry, where it focuses on high-value agricultural inputs rather than bulk commodities. The entity employs a workforce of 7,739 individuals and maintains a substantial market capitalization of $23.56 billion, reflecting its significant standing in the chemical manufacturing landscape. With an annual revenue of $4.58 billion, these valuation and earnings metrics indicate that the company commands a premium position in the global supply chain for fertilizers and specialty chemicals.

Santé financière

The company reported a trailing twelve-month revenue of $4.58 billion and generated a net income of $588.14 million, while achieving an EBITDA of $1.48 billion. The substantial gap between the $4.58 billion in revenue and the $588.14 million in net income reveals a cost structure characterized by operating expenses, taxes, and interest that consume approximately 87% of total sales before reaching the bottom line. Free cash flow stood at $429.63 million, a figure that demonstrates the company's capacity to generate liquidity after capital expenditures, providing financial flexibility for operational reinvestment or balance sheet management. Three distinct margin metrics further clarify profitability: the gross margin is 29.6%, the operating margin is 28.3%, and the profit margin is 12.9%. These figures indicate that while production costs are contained relative to sales, significant operational and tax burdens reduce the final return to shareholders. Regarding liquidity and leverage, the firm holds $2.72 billion in cash against $4.76 billion in total debt, resulting in a debt-to-equity ratio of 59.16. This leverage level suggests a balance sheet that utilizes debt financing but remains sensitive to interest rate fluctuations and commodity cycles. Short-term liquidity is robust, evidenced by a current ratio of 3.27, which indicates the company possesses more than three times the current assets necessary to cover its current liabilities. Furthermore, the return on equity is 9.7% and the return on assets is 5.2%, metrics that reveal management's effectiveness in utilizing shareholder capital and total assets to generate profits.

Évaluation de la valorisation

Valuation multiples for Sociedad Química y Minera de Chile S.A. show a trailing P/E ratio of 40.04 and a forward P/E of 15.02. The sharp divergence between the trailing and forward multiples implies that the market expects a significant deceleration in earnings growth or a substantial increase in future profitability to justify current valuations. The price-to-book ratio stands at 4.14, indicating that the market values the company at more than four times its book value, which suggests a premium pricing for its intangible assets or growth prospects. Alternative valuation metrics include a price-to-sales ratio of 5.15 and an EV/EBITDA of 18.93, figures that suggest the market is willing to pay a high multiple for revenue and cash earnings relative to peers. The stock's trading range over the past year spans from a 52-week low of $29.36 to a 52-week high of $86.13. Without a specific current price provided in the available facts, the position relative to this range cannot be calculated, but the wide spread between the high and low illustrates significant historical volatility. The beta value is 0.98, a figure that indicates the stock's price volatility moves almost in lockstep with the broader market, neither significantly amplifying nor dampening market swings.

Growth & Income

The company demonstrated impressive momentum with a revenue growth rate of 23.3% and an earnings growth rate of 52.3% year-over-year. The fact that earnings are growing at more than double the rate of revenue implies a potential expansion in operating leverage, cost efficiencies, or a shift toward higher-margin product mixes within the specialty nutrients portfolio. As a non-dividend payer, the company maintains a dividend yield of N/A and a payout ratio of 0.0%, indicating that it currently retains all net income rather than distributing cash to shareholders. This retention strategy allows the firm to reinvest earnings directly into capacity expansion, research and development for new chemical blends, or debt reduction to strengthen the balance sheet. Consequently, the overall growth and income profile is defined by aggressive earnings expansion and full earnings retention rather than income generation through dividend distributions.